| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -15.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PVLA returned +172.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +39.2% |
| 1 year | +172.8% |
| 5 years | -66.2% |
| 10 years | +13.9% |
| All-time high | $681.60 (Feb 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PVLA would be worth today ›No. Palvella Therapeutics, Inc. has not paid a dividend in the past 12 months.
Palvella Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol PVLA.
Palvella Therapeutics, Inc. is part of the Healthcare sector.
Palvella Therapeutics, Inc. has a market cap of 2.10B USD, based on the latest quote.
